.png){kind=small}
Discovery to conviction
BII Studio or Spin-off Builder plus rigorous scientific framing — built to earn investor and partner conviction early.
- Pre-seed / seed and grant-in-kind
- University and corporate IP routes
Poland & Central Europe · Biotech & life science
We help build the biotech ecosystem by connecting science, technology, and entrepreneurship
We partner at inception with science-first teams and institutions: shaping the first company narrative, building partner-ready data packages, and driving execution from early discovery to strategic partnerships and scale.
“From impossible to inevitable — for biotech ventures in Central Europe.”
We back technically ambitious teams from the beginning with venture building, market development, product acceleration and programme delivery, and the right network at the right moment.
About
Independent partner for teams turning hard science into adopted biotech products in Central Europe.
Biotech Innovation Institute is an operating partner for therapeutics, platforms, tools, and diagnostics — from early discovery narrative through partnering, regulatory and IP clarity, and execution rhythm. One conviction-led model: venture building, market development, product acceleration, expert network, and programme delivery.
Five pillars, one operating system
Every pillar is built for one goal: helping biotech to turn growth.
01 · VENTURE BUILDING
Studio, spin-offs, acceleration, EiR, investment readiness
Hands-on company creation around breakthrough science, with clear ownership models, investment readiness for capital and partners, and day-one execution discipline.
02 · ALLIANCES & MARKETS
EU and US market entry, corporates, funding, ambassadors
From first partner call to strategic alliances: EU and US market entry, corporate pathways, and funding leverage across the region.
03 · PRODUCT ACCELERATION & PM
Roadmaps, stage gates, integrated delivery
Compress timelines with disciplined acceleration — milestone clarity, cross-functional PMO, and execution rhythm from discovery through partnering.
04 · NETWORKING & KNOWLEDGE
Connect, roundtables, mentoring, reports
High-signal community formats where founders meet decision-makers, not noise.
05 · REGULATORY & IP
Regulatory, IP Strategy Design
Regulatory route mapping and evidence planning alongside IP landscaping, FTO, and filing strategy — aligned with your science and partnership milestones.
Equity in select portfolio EiR programme Product acceleration & PMO Policy & regulatory briefs Lab access partnerships CEE hub
Partners
Universities, companies, and organisations we collaborate with.
How winning teams get most out of BII
The strongest companies stack modules intentionally: venture building + funding + market access + expert community at the exact stage they need each.
From first customer to regional momentum
EU and US market entry and Ambassador network access layered with alliance execution that creates repeatable growth motion.
- Payer and pilot context for regulated products
- Soft-landing in new countries
Technical edge at operating speed
Product acceleration and integrated project management — stage gates, RAID cadence, and delivery confidence as programmes tighten toward milestones.
- Roadmaps and portfolio trade-offs
- Cross-functional PM with R&D and CMC
Signal-rich founder network
Roundtables, mentoring, and flagship convenings that compress learning cycles and open high-value relationships faster.
- Annual BII Connect and demo formats
- White papers and ecosystem reporting
Case studies
Platform partnering
Novel modality — pharma BD and CRO package
Positioning a discovery-stage platform for structured pharma conversations and outsourced study design; anonymised EU programme.
Overview · landing editionSpin-off
Academic spin-off — therapeutic asset
IP, team, target product profile outline, and first non-dilutive funding aligned for a biotech spin-off.
Overview · landing editionGrant
Consortium coordination
EU collaborative project: partner mapping, work packages, and reporting rhythm.
Overview · landing editionPublications and reports
Landscape analyses and ecosystem intelligence from our region.
Landscape
Polish biotech landscape overview
Summary and figures from the ecosystem overview (M. Kulczycka). Replace with your PDF link when available.
PDF link · when availableEvents
Conferences, webinars, and closed-door sessions for founders, investors, and translational teams.
Upcoming
BII Biotech Breakfast
Quarterly stakeholder breakfast — date TBA. Invitation-only.
Details · landing editionWebinar
EU grants and EIC for biotech R&D
Recorded session — registration for replay.
Details · landing editionDedicated paths
Choose your entry point — built for science-driven biotech and the partners who accelerate it.
For Academia
Universities, institutes, PI teams — commercialisation, grants, spin-offs.
Contact us →For startups
Therapeutics, platforms, tools, and diagnostics — CMC/regulatory path, BD, alliances, funding.
Contact us →For industry
Biopharma, CDMO/CRO, diagnostics, and adopters — partnering, pilots, and integration of novel science.
Contact us →